13F-HR filed by Artia Global Partners LP
Artia Global Partners LP filed this 13F-HR for the quarter ended 2024-03-31, filed 2024-05-15, with 49 holding rows worth $497,509,708.
- Accession
- 0001937964-24-000004
- Filer
- CIK 1937964
- Filed
- 2024-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2024
A holdings report, 49 entries on the cover page, a total value of $497,509,708 stated on the cover page (in dollars after the unit check, H1), rows summing to $497,509,708 with VALUE read as dollars as filed, 13F file number 028-23071. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ELI LILLY & CO | 532457958 | PUT | 115,000 | $89,465,400 | dollars as filed | put |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 691,743 | $88,819,801 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 92,593 | $72,033,650 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 379,200 | $50,035,440 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 433,580 | $35,553,560 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 90,821 | $16,538,504 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 210,096 | $14,538,643 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 34,238 | $13,480,185 | dollars as filed | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 190,752 | $12,923,448 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 28,900 | $12,080,489 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 87,848 | $7,010,270 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 724,685 | $6,594,634 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 89,525 | $6,276,598 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 45,000 | $6,206,400 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 87,040 | $5,419,110 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 76,255 | $5,208,979 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 61,590 | $4,092,656 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 85,765 | $4,014,660 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 124,440 | $3,600,049 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 119,488 | $3,392,264 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 118,236 | $3,207,743 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 53,930 | $2,654,435 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 15,894 | $2,402,696 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 52,492 | $2,303,349 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 50,171 | $2,259,200 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 130,790 | $2,104,411 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 51,714 | $2,049,943 | dollars as filed | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 6,905 | $1,870,910 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 47,949 | $1,805,280 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 40,924 | $1,751,547 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 40,000 | $1,722,000 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 40,000 | $1,651,200 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 100,000 | $1,490,000 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 421,359 | $1,390,485 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 54,285 | $1,283,840 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 137,308 | $1,233,026 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 52,476 | $1,133,482 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 51,500 | $1,064,505 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 147,485 | $1,057,467 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 24,298 | $1,047,730 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 64,007 | $942,183 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 39,478 | $842,066 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 21,397 | $691,337 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 35,452 | $530,007 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 58,190 | $441,662 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 1,557 | $415,781 | dollars as filed | |
| EFFECTOR THERAPEUTICS INC | 28202V907 | CALL | 25,000 | $359,750 | dollars as filed | call |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 86,002 | $274,346 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 95,170 | $244,587 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001937964-24-000004 | this filing | 2024-05-15 | acceptance time not in the bulk data set |